1. Pituitary adenylate cyclase activating polypeptide (PACAP1-38) exerts both pro and anti-apoptotic effects on postnatal retinal development in rat
   Nyisztor Zsolt et al, 2018, Neuroscience CrossRef
2. PACAP deficiency aggravates atherosclerosis in ApoE deficient mice
   Erik Rasbach et al, 2018, Immunobiology CrossRef
3. Decreased synovial fluid pituitary adenylate cyclase-activating polypeptide (PACAP) levels may reflect disease severity in post-traumatic knee osteoarthritis after anterior cruciate ligament injury
   Bing-Yin Sun et al, 2019, Peptides CrossRef
4. The Neuroprotective Peptide PACAP1-38 Contributes to Horizontal Cell Development in Postnatal Rat Retina
   Viktoria Denes et al, 2019, Invest. Ophthalmol. Vis. Sci. CrossRef
5. Protective Effects of PACAP in Peripheral Organs
   Denes Toth et al, 2020, Front. Endocrinol. CrossRef
6. PACAP-38 and PAC1 Receptor Alterations in Plasma and Cardiac Tissue Samples of Heart Failure Patients
   Dóra Szabó et al, 2022, IJMS CrossRef
7. Enhancing endothelial colony-forming cells for treating diabetic vascular complications: challenges and clinical prospects
   Yaqiong Liu et al, 2024, Front. Endocrinol. CrossRef
8. Exploring the Role of Neuropeptide PACAP in Cytoskeletal Function Using Spectroscopic Methods
   Roland Gábor Vékony et al, 2024, IJMS CrossRef
9. Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
   Gabriella Horvath et al, 2022, IJMS CrossRef